ReviewCell & bioscience2026
The impact and mechanisms of preeclampsia on offspring neurodevelopment.
Review in Cell & bioscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Preeclampsia (PE) is a pregnancy-specific hypertensive disorder that has significant impact on offspring neurodevelopment. In this review, we first summarize the clinical and epidemiological evidence that PE disrupts fetal brain development while increasing the risk of neuropsychiatric diseases such as autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in offspring. PE exposure is associated with altered brain growth and cortical morphology and white-matter microstructure in offspring, and with persistent deficits in cognition, emotion and social ability. We then propose the pathophysiological mechanisms underlying how PE exposure influences offspring neurodevelopment and thus increases the susceptibility of neuropsychiatric diseases in offspring from the studies of animal models. We pay attention to the heterogeneity across studies related to gestational age at delivery, fetal growth restriction (FGR) and postnatal exposures, highlighting the sex-specific mechanisms and translational therapeutic targets. Lastly, we discuss future directions including sexually dimorphic effects of PE and “two-hits” experimental paradigms to model prenatal-postnatal interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.